Tag: myosin
Bristol Myers Squibb launches Kopozgo in India for treatment of symptomatic...
Kopozgo is the first and only cardiac myosin inhibitor that specifically targets the underlying pathophysiology of obstructive HCM in India
Researchers make new discovery in battle against malaria
Indian researchers have identified a novel anti-malarial peptide that could be used in combination with other antimalarials for blocking the Plasmodium falciparum parasite from infecting blood cells.......................






















































